Financials
- Market Capitalization 137.3 B
- Employee 6 400
- Founded 1989
- CEO Reshma Kewalramani
- Website www.vrtx.com
- Headquarter Massachusetts, United States
- FIGI BBG000C1S2X2
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
28.93
売上高対価格比率
10.13
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 208 | REGN Regeneron Pharmaceuticals, Inc. - Common Stock | 794.19 USD | -1.67% | -4.83% | +9.06% | +36.80% | 81.77 B USD | ||
| 263 | ARGX argenx SE - American Depositary Shares | 1023.21 USD | -3.37% | -0.01% | +17.29% | +43.71% | 63.32 B USD | ||
| 296 | MRNA Moderna, Inc. - Common Stock | 137.99 USD | -3.35% | -3.30% | +138.53% | +476.64% | 55.09 B USD | ||
| 351 | RVMD Revolution Medicines, Inc. - Common Stock | 207.88 USD | -6.00% | -0.57% | +8.27% | +275.23% | 44.56 B USD |